One study found that ephrin type-A receptor 2 (EphA2) was prominently upregulated in urinary EVs, and EV-EphA2-CD9 ELISA performed well in diagnosing early bladder cancer [173]. This evidence concerns the gene EPHA2 and urinary bladder cancer.